GB9815170D0 - 4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7YL)butanoyl-glycyl-3(S)-Quinolin-3- YL-B-alanine and salts thereof - Google Patents

4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7YL)butanoyl-glycyl-3(S)-Quinolin-3- YL-B-alanine and salts thereof

Info

Publication number
GB9815170D0
GB9815170D0 GBGB9815170.7A GB9815170A GB9815170D0 GB 9815170 D0 GB9815170 D0 GB 9815170D0 GB 9815170 A GB9815170 A GB 9815170A GB 9815170 D0 GB9815170 D0 GB 9815170D0
Authority
GB
United Kingdom
Prior art keywords
naphthyridin
butanoyl
glycyl
quinolin
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9815170.7A
Other versions
GB2327672A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9815170D0 publication Critical patent/GB9815170D0/en
Publication of GB2327672A publication Critical patent/GB2327672A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9815170A 1997-07-23 1998-07-13 4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7-yl)butanoyl-glycyl-3(S)-quinolin-3-yl-beta-alanine Withdrawn GB2327672A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5353697P 1997-07-23 1997-07-23

Publications (2)

Publication Number Publication Date
GB9815170D0 true GB9815170D0 (en) 1998-09-09
GB2327672A GB2327672A (en) 1999-02-03

Family

ID=21984958

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9815170A Withdrawn GB2327672A (en) 1997-07-23 1998-07-13 4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7-yl)butanoyl-glycyl-3(S)-quinolin-3-yl-beta-alanine

Country Status (1)

Country Link
GB (1) GB2327672A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
JP4064059B2 (en) 1998-04-09 2008-03-19 明治製菓株式会社 Aminopiperidine derivatives as integrin αVβ3 antagonists
EP1209152A4 (en) 1999-08-05 2003-03-12 Meiji Seika Kaisha Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alpha v beta 3 antagonism
CA2448160A1 (en) * 2001-05-25 2002-12-05 Queen's University At Kingston Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
US7115596B2 (en) 2002-12-20 2006-10-03 Pharmacia Corporation Thiazole compounds as integrin receptor antagonists derivatives
EP2336117A1 (en) 2005-05-26 2011-06-22 Neuron Systems, Inc Heterocyclic compounds for treating retinal diseases
JP5885670B2 (en) 2009-12-11 2016-03-15 アルデイラ セラピューティクス， インコーポレイテッド Compositions and methods for the treatment of macular degeneration
SG11201505587YA (en) 2013-01-23 2015-08-28 Aldeyra Therapeutics Inc Toxic aldehyde related diseases and treatment
JP6947406B2 (en) 2015-08-21 2021-10-13 アルデイラ セラピューティクス， インコーポレイテッド Deuterated compounds and their use
MX2018013472A (en) 2016-05-09 2019-02-28 Aldeyra Therapeutics Inc Combination treatment of ocular inflammatory disorders and diseases.
US10414732B2 (en) 2017-03-16 2019-09-17 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
WO2019075136A1 (en) 2017-10-10 2019-04-18 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
EP3833660A4 (en) 2018-08-06 2022-05-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CN113784954A (en) 2019-05-02 2021-12-10 奥尔德拉医疗公司 Polymorphic compounds and their uses
WO2020223717A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
EP4149470A4 (en) 2020-05-13 2024-04-24 Aldeyra Therapeutics, Inc. PHARMACEUTICAL FORMULATIONS AND USES THEREOF

Also Published As

Publication number Publication date
GB2327672A (en) 1999-02-03

Similar Documents

Publication Publication Date Title
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
PL334218A1 (en) Derivatives of 2-(purin-9-yl)-tetrahydrofurane 3,4-diole
PL337057A1 (en) 2-substituted 4,5-diarylimidazoles
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
NZ314419A (en) Substituted 2,4-aryl-3-hydroxyalkyl pyridines; preparation and medicaments
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
IL127566A0 (en) Substituted 6,5-hetero- bicyclic derivatives
HK1019597A1 (en) Substituted 6, 6-hetero-bicyclic derivatives
ZA986588B (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
ZA986421B (en) 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use.
GB9815170D0 (en) 4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7YL)butanoyl-glycyl-3(S)-Quinolin-3- YL-B-alanine and salts thereof
PL348668A1 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
HUP9901685A3 (en) Colchicine derivatives, the use thereof and formulations containing them
IL126702A0 (en) 2,4-Diaminopyrimidine derivatives
IL122372A0 (en) Substituted piperidine-2,6-diones their preparation and use
ZA989571B (en) 2-Substituted 1,2-Benzoisonthiazole derivatives, their preparation and use.
HUP0000491A3 (en) Herbicidal substituted 4-benzoyl-pyrazole derivatives, preparation and use thereof
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
AU4506499A (en) Novel 2,4-diaminophenol derivatives and the use thereof
SG70589A1 (en) 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
NZ301453A (en) 4-(substituted phenyl),4-(substituted carboxyl, carboxylamide or alkyl)-cyclohexan-1-one derivatives and medicaments
ZA981849B (en) (-)E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethylpiperidine and its antidiarrhoeal use
ZA981529B (en) Substituted 2,4-diaminopyrimidine
Muminović ASTRONOMIJA u osvit trećeg milenijuma

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)